COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

Children show signs of post-COVID lung damage on MRI.

Advanced MRI shows decreased lung function in kids with persistent COVID symptoms

New research findings may help explain why children recovering from COVID-19 continue to struggle with lingering fatigue. 

COVID-19 linked to accelerated plaque growth, long-term risk of heart attack or stroke

These risks appear to be present regardless of a person's age or health at the time of infection.

COVID may cause 'rapid progression' of coronary plaques, imaging study suggests

These elevated risks extend well beyond the initial infection period, researchers caution.

Thumbnail

COVID lung damage evident in up to 1/3 of cases 12 months after infection

These findings are not exclusive to severe cases of the virus and have been observed in individuals who reported having more moderate infections.

COVID-19 coronavirus mask smell

Chemical alterations in the brain hint at whether loss of smell will return post-COVID

Researchers have identified what they believe could serve as imaging biomarkers that predict recovery from anosmia after contracting the virus. 

differentiating between malignant and vaccine-related lymphadenopathy

7 COVID vaccine complications: The radiologist's role in identifying adverse reactions

Although serious adverse events related to COVID-19 vaccines are rare, some are life-threatening. It is important that radiologists are aware of how these complications present.

long covid brainstem damage

Ultra-high field MRI implicates long COVID in brainstem damage

Researchers have used 7T MRI to demonstrate that former COVID-19 inpatients are susceptible to persistent brainstem abnormalities associated with long-haul COVID symptoms.

Thumbnail

MRI study pinpoints neural roots of lingering fatigue post-COVID infection

Some of the findings observed have also been reported in patients who have multiple sclerosis, “which could suggest partially shared pathophysiological substrates of fatigue symptoms,” researchers indicated. 

Around the web

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?